Chinese views of euthanasia: A population-based study from Hong Kong to inform policy
Abstract
Background: Medically-assisted death (MAD), which includes active euthanasia and physician-assisted suicide, is currently prohibited in all countries in Asia. Despite calls for greater public dialogue there are no large-scale studies on the acceptability of MAD to inform health policy.
Objectives: As Hong Kong has one of the oldest populations in the world, this study sought to examine the cultural acceptability of MAD among Chinese adults and factors associated with support/opposition.
Methods: An anonymous, random telephone and internet survey on Hong Kong Chinese adults (age > =35 years) was conducted in May-December 2024 (n = 3100). Respondents were asked their views of legalizing MAD across 7 clinical scenarios and their reasons. Multivariable analysis was conducted to assess correlates of support/opposition to MAD.
Results: The proportion who supported legalization of MAD for the following clinical scenarios varied considerably: terminally ill patients in severe pain (88.8%), non-terminal patients with an irreversible condition and severe pain (84.2%), vegetative patients with advance directives (77.6%), patients with severe disability (60.3%), severe dementia patients with advance directives (46.8%), very old people who wish to discontinue living (31.1%), and patients with unremitting mental illness (20.5%). While 80% accepted MAD for at least 3 clinical scenarios only 5.7% rejected all MAD. Nearly half of the respondents said that they would consider seeking MAD overseas if faced with an intolerable disease. Multivariable models revealed that support for MAD was significantly associated with younger age, belief in afterlife, poor health status, low levels of filial piety, high income, poor perception of health services, and low perception of MAD harms (OR: 1.37-3.53).
Conclusions: There is sufficient public support for MAD in Hong Kong for greater policy discussion. Rapidly aging countries in the East Asia region should explore cultural acceptability of MAD.
Key messages: • There is high levels of support for medically assisted death among urban Chinese in high-income regions. Attitudes may be similar for ethnic Chinese living in western countries.
• Perceptions of health care accessibility, quality and affordability influence support for medically-assisted death.
Related
- Analysis of health impacts associated with adopting permanent standard time or permanent daylight saving time to inform policy in Canada.
- What is known about consumer leadership across healthcare services, research, policy and education? A scoping review to inform change beyond visibility and the ‘glass box’ effect
- Genomics screening views and practices in South East Asian, Indian and Chinese populations: a scoping review.
- Public views and acceptability of policies designed to achieve a healthy weight across the United Kingdom: qualitative analysis of the role of government mistrust and legitimacy of policy actors
- X.2.PK.2. Embedding evidence in action: lessons from the UK to inform climate and public policy across Europe
BibTeX
@article{kim2026chinese,
title = {{Chinese views of euthanasia: A population-based study from Hong Kong to inform policy}},
author = {JH Kim and RY Chung and CK Chow and E Jackson and D Dong and MC Liu and EK Yeoh},
journal = {The European Journal of Public Health},
year = {2026},
month = oct,
doi = {10.1093/eurpub/ckag169.1304},
url = {https://doi.org/10.1093/eurpub/ckag169.1304},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Chinese views of euthanasia: A population-based study from Hong Kong to inform policy
AU - JH Kim
AU - RY Chung
AU - CK Chow
AU - E Jackson
AU - D Dong
AU - MC Liu
AU - EK Yeoh
PY - 2026
DA - 2026/10/01
JO - The European Journal of Public Health
DO - 10.1093/eurpub/ckag169.1304
UR - https://doi.org/10.1093/eurpub/ckag169.1304
AB - Background: Medically-assisted death (MAD), which includes active euthanasia and physician-assisted suicide, is currently prohibited in all countries in Asia. Despite calls for greater public dialogue there are no large-scale studies on the acceptability of MAD to inform health policy. Objectives: As Hong Kong has one of the oldest populations in the world, this study sought to examine the cultural acceptability of MAD among Chinese adults and factors associated with support/opposition. Methods: An anonymous, random telephone and internet survey on Hong Kong Chinese adults (age > =35 years) was conducted in May-December 2024 (n = 3100). Respondents were asked their views of legalizing MAD across 7 clinical scenarios and their reasons. Multivariable analysis was conducted to assess correlates of support/opposition to MAD. Results: The proportion who supported legalization of MAD for the following clinical scenarios varied considerably: terminally ill patients in severe pain (88.8%), non-terminal patients with an irreversible condition and severe pain (84.2%), vegetative patients with advance directives (77.6%), patients with severe disability (60.3%), severe dementia patients with advance directives (46.8%), very old people who wish to discontinue living (31.1%), and patients with unremitting mental illness (20.5%). While 80% accepted MAD for at least 3 clinical scenarios only 5.7% rejected all MAD. Nearly half of the respondents said that they would consider seeking MAD overseas if faced with an intolerable disease. Multivariable models revealed that support for MAD was significantly associated with younger age, belief in afterlife, poor health status, low levels of filial piety, high income, poor perception of health services, and low perception of MAD harms (OR: 1.37-3.53). Conclusions: There is sufficient public support for MAD in Hong Kong for greater policy discussion. Rapidly aging countries in the East Asia region should explore cultural acceptability of MAD. Key messages: • There is high levels of support for medically assisted death among urban Chinese in high-income regions. Attitudes may be similar for ethnic Chinese living in western countries. • Perceptions of health care accessibility, quality and affordability influence support for medically-assisted death.
SN - 1101-1262
SN - 1464-360X
ER -